JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120046

NBQX disodium salt, AMPA / kainate antagonist

5

(1 Review)

|

(74 Publications)

NBQX disodium salt (ab120046) is a water soluble, potent, selective and competitive AMPA/kainate receptor antagonist. Neuroprotective and anticonvulsant in vivo. MW 380.25.

- Available in different sizes to fit your experimental needs
- Cited in over 60 publications
2 Images
Chemical Structure - NBQX disodium salt, AMPA / kainate antagonist (AB120046)
  • Chemical Structure

Lab

Chemical Structure - NBQX disodium salt, AMPA / kainate antagonist (AB120046)

2D chemical structure image of ab120046, NBQX disodium salt, AMPA / kainate antagonist

Functional Studies - NBQX disodium salt, AMPA / kainate antagonist (AB120046)
  • FuncS

Unknown

Functional Studies - NBQX disodium salt, AMPA / kainate antagonist (AB120046)

ab96379 staining MEK1 (phospho S298) in SK-N-SH cells treated with NBQX disodium salt (ab120046), by ICC/IF. Decrease in MEK1 (phospho S298) expression correlates with increased concentration of NBQX disodium salt, as described in literature.
The cells were incubated at 37°C for 24h in media containing different concentrations of ab120046 (NBQX disodium salt) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab96379 (1/100 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.

Key facts

CAS number

479347-86-9

Purity

>98%

Form

Solid

form

Molecular weight

380.25 Da

Molecular formula

C<sub>1</sub><sub>2</sub>H<sub>6</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>6</sub>S

PubChem

3272523

Nature

Synthetic

Biochemical name

6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione, Disodium Salt

Biological description

Water soluble, potent, selective and competitive AMPA/kainate receptor antagonist. Neuroprotective and anticonvulsant in vivo.

Canonical smiles

C1=CC2=C3C(=CC(=C2C(=C1)S(=O)(=O)N)[N+](=O)[O-])N=C(C(=N3)[O-])[O-].[Na+].[Na+]

InChi

InChI=1S/C12H8N4O6S.2Na/c13-23(21,22)8-3-1-2-5-9(8)7(16(19)20)4-6-10(5)15-12(18)11(17)14-6;;/h1-4H,(H,14,17)(H,15,18)(H2,13,21,22);;/q;2*+1/p-2

InChiKey

SVJKYIUJRJEABK-UHFFFAOYSA-L

IUPAC Name

disodium;6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-diolate

Product details

Check out our range of AMPA / kainate antagonist here

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Dysfunction in GluR1 and associated AMPA receptors has been implicated in conditions like Alzheimer's disease and epilepsy. Alzheimer's disease exhibits decreased synaptic transmission and plasticity linked to impaired GluR1 function and its interactions with NMDA receptors. In epilepsy abnormal GluR1 activity may contribute to heightened neuronal excitability and seizure propagation. Targeting GluR1 or associated pathways offers potential for therapeutic interventions in these disorders possibly through drugs such as memantine and NBQX which modulate receptor activity.
Pathways

The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.

Biological function summary

The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.

Glutamate Receptor 1 (AMPA subtype) also known as GluR1 is a subunit of the AMPA receptor complex which mediates fast synaptic transmission in the central nervous system. It is an ionotropic receptor for glutamate functioning by opening ion channels to allow the flow of Na+ and Ca2+ ions across the cell membrane contributing to excitatory neurotransmission. The GluR1 subunit has a molecular mass of approximately 100 kDa. This receptor is commonly expressed in the brain regions such as the hippocampus and the cerebral cortex playing an important role in synaptic plasticity and memory formation.

Product protocols

Publications (74)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:5663 PubMed40595546

2025

Thalamocortical feedback selectively controls pyramidal neuron excitability.

Applications

Unspecified application

Species

Unspecified reactive species

Federico Brandalise,Ronan Chéreau,I-Wen Chen,David van Oorschot,Claudia Morin Raig,Tanika Bawa,Nandkishor Mule,Stéphane Pagès,Foivos Markopoulos,Anthony Holtmaat

eLife 13: PubMed40013677

2025

Characterization of direct Purkinje cell outputs to the brainstem.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher H Chen,Zhiyi Yao,Shuting Wu,Wade G Regehr

eLife 13: PubMed39819796

2025

Realistic mossy fiber input patterns to unipolar brush cells evoke a continuum of temporal responses comprised of components mediated by different glutamate receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Vincent Huson,Wade G Regehr

Science advances 11:eadq6663 PubMed39823338

2025

Control of striatal circuit development by the chromatin regulator .

Applications

Unspecified application

Species

Unspecified reactive species

Kyuhyun Choi,Nathan T Henderson,Emily R Feierman,Sean Louzon,Jamie Galanaugh,Felicia Davatolhagh,Isha Bhandaru,David J Tischfield,Stewart A Anderson,Erica Korb,Marc V Fuccillo

The Journal of neuroscience : the official journal of the Society for Neuroscience 44: PubMed39147589

2024

Heterogeneity in Slow Synaptic Transmission Diversifies Purkinje Cell Timing.

Applications

Unspecified application

Species

Unspecified reactive species

Riya Elizabeth Thomas,Franziska Mudlaff,Kyra Schweers,William Todd Farmer,Aparna Suvrathan

iScience 27:110145 PubMed38952682

2024

Layer specific regulation of critical period timing and maturation of mouse visual cortex by endocannabinoids.

Applications

Unspecified application

Species

Unspecified reactive species

Taisuke Yoneda,Katsuro Kameyama,Takahiro Gotou,Keiko Terata,Masahiro Takagi,Yumiko Yoshimura,Kenji Sakimura,Masanobu Kano,Yoshio Hata

Nature communications 15:5095 PubMed38876987

2024

Scanless two-photon voltage imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Ruth R Sims,Imane Bendifallah,Christiane Grimm,Aysha S Mohamed Lafirdeen,Soledad Domínguez,Chung Yuen Chan,Xiaoyu Lu,Benoît C Forget,François St-Pierre,Eirini Papagiakoumou,Valentina Emiliani

Nature neuroscience 27:484-496 PubMed38233682

2024

The developmental timing of spinal touch processing alterations predicts behavioral changes in genetic mouse models of autism spectrum disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Aniqa Tasnim,Ilayda Alkislar,Richard Hakim,Josef Turecek,Amira Abdelaziz,Lauren L Orefice,David D Ginty

eLife 12: PubMed37490401

2023

Neuropeptide Y-expressing dorsal horn inhibitory interneurons gate spinal pain and itch signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Kieran A Boyle,Erika Polgar,Maria Gutierrez-Mecinas,Allen C Dickie,Andrew H Cooper,Andrew M Bell,Evelline Jumolea,Adrian Casas-Benito,Masahiko Watanabe,David I Hughes,Gregory A Weir,John S Riddell,Andrew J Todd

Cell reports 40:111440 PubMed36170833

2022

Dopamine D2 receptors bidirectionally regulate striatal enkephalin expression: Implications for cocaine reward.

Applications

Unspecified application

Species

Unspecified reactive species

Kathy Z Dai,In Bae Choi,Ryan Levitt,Mariah B Blegen,Alanna R Kaplan,Aya Matsui,J Hoon Shin,Miriam E Bocarsly,Eleanor H Simpson,Christoph Kellendonk,Veronica A Alvarez,Lauren K Dobbs
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com